Clinical Trials Directory

Trials / Completed

CompletedNCT04799509

Assessment of the 90-day Mortality Risk Score After VATS Lobectomy

Assessment of the 90-day Mortality Risk Score After Video-assisted Thoracoscopic Lobectomy in the Italian VATS Group Cohort

Status
Completed
Phase
Study type
Observational
Enrollment
2,209 (actual)
Sponsor
Università degli Studi dell'Insubria · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

A five classes (A-E) aggregate risk score predicting 90-day mortality after video-assisted thoracoscopic lobectomy for lung cancer, including as independent factors male sex (3 points), carbon monoxide lung diffusion capacity \<60% (1 point) and operative time \>150 minutes (1 point), has been recently published. This study aims to assess the effectiveness and reliability of this risk model in a large, independent cohort of patients, in order to confirm its generalizability.

Detailed description

From the Italian VATS Group Database, we selected patients who underwent video-assisted thoracoscopic lobectomy for non-small cell lung cancer. We calculated the aggregate risk score and the corresponding class of 90-day mortality risk for each patient. The correlation between risk classes and mortality rates was tested by Spearman's rho-test. Model calibration was evaluated by Hosmer-Lemeshow goodness-of-fit test.

Conditions

Interventions

TypeNameDescription
PROCEDUREVATS lobectomyVATS lobectomy

Timeline

Start date
2014-01-01
Primary completion
2018-11-27
Completion
2018-11-27
First posted
2021-03-16
Last updated
2021-03-22

Source: ClinicalTrials.gov record NCT04799509. Inclusion in this directory is not an endorsement.